  See all
 |
Articles: Neuro/Psych pharmacology |
Prior Articles
Safety and Tolerability of Donepezil, Rivastigmine and Galantamine for Patients with Alzheimer's Disease: Systematic Review of the 'Real-World' Evidence
Dementia and Geriatric Cognitive Disorders, 11/09/09
A Systematic Review of Angiotensin Receptor Blockers in Preventing Stroke
Stroke, 11/09/09 Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia
Neuropsychopharmacology, 11/09/09 Inhaled tiotropium bromide and risk of stroke
British Journal of Clinical Pharmacology, 11/09/09 Gamma and Delta Neural Oscillations and Association with Clinical Symptoms under Subanesthetic Ketamine
Neuropsychopharmacology, 11/09/09 More Aroused, Less Fatigued: Fatty Acid Amide Hydrolase Gene Polymorphisms Influence Acute Response to Amphetamine
Neuropsychopharmacology, 11/09/09 Adjunctive Divalproex Versus Placebo for Children With ADHD and Aggression Refractory to Stimulant Monotherapy
American Journal of Psychiatry, 11/06/09 Metabolic and Cardiac Side Effects of Second-generation Antipsychotics: What Every Clinician Should Know
Journal of Pharmacy Practice, 11/05/09 Sibutramine for weight gain attenuation during smoking cessation with varenicline: A pilot study
Nicotine & Tobacco Research, 11/05/09 Rituximab in the management of refractory myasthenia gravis
Muscle & Nerve, 11/05/09 Critical appraisal of the long-term impact of memantine in treatment of moderate to severe Alzheimer’s disease
Neuropsychiatric Disease and Treatment, 11/04/09
Free full text
Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide
Neuropsychiatric Disease and Treatment, 11/04/09
Free full text
Variability in the Prescription of Cholinesterase Inhibitors and Memantine
Dementia and Geriatric Cognitive Disorders, 11/03/09 The 5-HT1B Receptor: A Novel Target for the Pathophysiology of Depression
Current Drug Targets, 11/03/09 Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation
Multiple Sclerosis, 11/03/09 The brain angiotensin IV/AT4 receptor system as a new target for the treatment of Alzheimers disease
Drug Development Research, 11/03/09 Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial
The Lancet, 11/03/09 Mecamylamine ? a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders
Expert Opinion in Pharmacotherapy, 11/02/09 Dexmethylphenidate for attention deficit hyperactivity disorder
Expert Opinion in Pharmacotherapy, 11/02/09 Pharmacotherapy of postpartum depression
Expert Opinion in Pharmacotherapy, 11/02/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
